DK422086A - Xanthinderivater - Google Patents

Xanthinderivater Download PDF

Info

Publication number
DK422086A
DK422086A DK422086A DK422086A DK422086A DK 422086 A DK422086 A DK 422086A DK 422086 A DK422086 A DK 422086A DK 422086 A DK422086 A DK 422086A DK 422086 A DK422086 A DK 422086A
Authority
DK
Denmark
Prior art keywords
xanthine derivatives
xanthine
derivatives
Prior art date
Application number
DK422086A
Other languages
English (en)
Other versions
DK422086D0 (da
Inventor
Zoltan Kis
John Morley
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858522096A external-priority patent/GB8522096D0/en
Priority claimed from GB858526504A external-priority patent/GB8526504D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK422086D0 publication Critical patent/DK422086D0/da
Publication of DK422086A publication Critical patent/DK422086A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK422086A 1985-09-05 1986-09-03 Xanthinderivater DK422086A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858522096A GB8522096D0 (en) 1985-09-05 1985-09-05 Organic compounds
GB858526504A GB8526504D0 (en) 1985-10-28 1985-10-28 Organic compounds

Publications (2)

Publication Number Publication Date
DK422086D0 DK422086D0 (da) 1986-09-03
DK422086A true DK422086A (da) 1987-03-06

Family

ID=26289737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK422086A DK422086A (da) 1985-09-05 1986-09-03 Xanthinderivater

Country Status (15)

Country Link
EP (1) EP0215736B1 (da)
JP (1) JPH0692406B2 (da)
KR (1) KR900008569B1 (da)
AU (1) AU594363B2 (da)
CA (1) CA1266470A (da)
DE (1) DE3673734D1 (da)
DK (1) DK422086A (da)
ES (1) ES2001944A6 (da)
FI (1) FI863550A (da)
GR (1) GR862252B (da)
HU (1) HU197746B (da)
IL (1) IL79934A (da)
NZ (1) NZ217448A (da)
PL (1) PL149932B1 (da)
PT (1) PT83305B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033922T3 (es) * 1986-08-28 1993-04-01 Sandoz Ag Procedimiento para preparar nuevos derivados de xantina.
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
JP2006329451A (ja) * 2005-05-23 2006-12-07 Sanoh Industrial Co Ltd 熱交換器用伝熱管

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1076683B (de) * 1958-12-16 1960-03-03 Schering Ag Verfahren zur Herstellung der Ameisensaeureester von 1-Alkinylcycloalkanolen
FR2531085A1 (fr) * 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
IL79934A0 (en) 1986-12-31
KR870003107A (ko) 1987-04-15
HUT44552A (en) 1988-03-28
DK422086D0 (da) 1986-09-03
KR900008569B1 (ko) 1990-11-24
AU594363B2 (en) 1990-03-08
AU6230786A (en) 1987-03-12
JPH0692406B2 (ja) 1994-11-16
PL261284A1 (en) 1988-07-21
ES2001944A6 (es) 1988-07-01
IL79934A (en) 1990-06-10
PT83305B (pt) 1989-05-12
FI863550A (fi) 1987-03-06
EP0215736A1 (en) 1987-03-25
HU197746B (en) 1989-05-29
FI863550A0 (fi) 1986-09-03
DE3673734D1 (de) 1990-10-04
NZ217448A (en) 1989-10-27
PT83305A (en) 1986-10-01
GR862252B (en) 1986-12-31
PL149932B1 (en) 1990-04-30
EP0215736B1 (en) 1990-08-29
CA1266470A (en) 1990-03-06
JPS6263585A (ja) 1987-03-20

Similar Documents

Publication Publication Date Title
DK190486D0 (da) Xanthiner
DK263587D0 (da) Imidazoquinolinyletherderivater
DK82087A (da) Pyrocatecholderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
DK69887D0 (da) Dichloranilinderivater
DK448787A (da) Xanthinderivater
DK693587D0 (da) Alkansulfonanilidderivater
DE3675846D1 (de) Guaninderivate.
DK81888D0 (da) Dibenzoxepinderivater
DK109186D0 (da) Dihydropyridazinonderivater
DK691287D0 (da) 5-floururacilderivater
DK422086D0 (da) Xanthinderivater
DK71187A (da) Purinderivater
DK491786A (da) Dichloranilinderivater
BR8606663A (pt) Derivados de triazolil-quinolina
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
DK556386A (da) Quinilinderivater
DK271088D0 (da) Tienopyridinderivater
DK303886A (da) Secocanthinderivater
DK440687D0 (da) Bicyclooctanderivater
DK229887D0 (da) Alkenamidderivater
DK619187A (da) Isoindolderivater
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
KR880700821A (ko) 데--데옥시테이코플라닌 유도체
DK435087A (da) Isoprenderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment